← Leaderboards
L Joseph Wheat
Indiana Univ-Purdue Univ At Indianapolis
$0
Attributed
$0
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding mix
By agency
NIH$0 · 4
By mechanism
M01$0 · 4
Top collaborators
No co-investigators on record.
Most similar at Indiana Univ-Purdue Univ At Indianapolis
Same institution · by research overlap
- Kenneth H. Fife$1,137,888
- Md Michael Frank$0
- Joseph Wheat$0
- William Joseph McBride$23,558,304
- Michael P Dube$3,435,340
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectClinical ResearchHiv InfectionsHuman Therapy EvaluationDrug Screening /EvaluationAids TherapyReverse Transcriptase InhibitorsCombination ChemotherapyDosage FormsDrug Adverse EffectEsophagus DisorderHuman DataIndinavirKaposi'S SarcomaLamivudineMicroorganism Disease ChemotherapyNeoplasm /Cancer EpidemiologyNonhodgkin'S LymphomaOral AdministrationOral Pharyngeal DisorderSaquinavirTriazolesAdenine AnalogZidovudine
Grant awards (28)
ADEFOVIR DIPIVOXIL, INDINAVIR, ZIDOVUDINE, LAMIVUDINE IN VARIOUS DOSE$0
M01 · FY2002 · RR
SAQUINAVIR SOFT GEL CAP TID IN COMBO W/ 2 NRTS VS SAQUINAVIR BID IN H$0
M01 · FY2002 · RR
AIDS RELATED NON HODGKINS LYMPHOMA, KAPOSIS SARCOMA &OTHER MALIGNANC$0
M01 · FY2002 · RR
SCH 56592 IN TREATMENT OF AZOLE REFRACTORY CANDIDIASIS IN HIV$0
M01 · FY2002 · RR
SAQUINAVIR SOFT GEL CAP TID IN COMBO W/ 2 NRTS VS SAQUINAVIR BID IN H$0
M01 · FY2001 · RR
AIDS RELATED NON HODGKINS LYMPHOMA, KAPOSIS SARCOMA &OTHER MALIGNANC$0
M01 · FY2001 · RR
SCH 56592 IN TREATMENT OF AZOLE REFRACTORY CANDIDIASIS IN HIV$0
M01 · FY2001 · RR
ADEFOVIR DIPIVOXIL, INDINAVIR, ZIDOVUDINE, LAMIVUDINE IN VARIOUS DOSE$0
M01 · FY2001 · RR
AIDS RELATED NON HODGKINS LYMPHOMA, KAPOSIS SARCOMA &OTHER MALIGNANC$0
M01 · FY2000 · RR
AIDS RELATED NON HODGKINS LYMPHOMA, KAPOSIS SARCOMA &OTHER MALIGNANC$0
M01 · FY2000 · RR
SCH 56592 IN TREATMENT OF AZOLE REFRACTORY CANDIDIASIS IN HIV$0
M01 · FY2000 · RR
SCH 56592 IN TREATMENT OF AZOLE REFRACTORY CANDIDIASIS IN HIV$0
M01 · FY2000 · RR
SCH 56592 IN TREATMENT OF AZOLE REFRACTORY CANDIDIASIS IN HIV$0
M01 · FY2000 · RR
SCH 56592 IN TREATMENT OF AZOLE REFRACTORY CANDIDIASIS IN HIV$0
M01 · FY2000 · RR
SAQUINAVIR SOFT GEL CAP TID IN COMBO W/ 2 NRTS VS SAQUINAVIR BID IN H$0
M01 · FY2000 · RR
ADEFOVIR DIPIVOXIL, INDINAVIR, ZIDOVUDINE, LAMIVUDINE IN VARIOUS DOSE$0
M01 · FY2000 · RR
ADEFOVIR DIPIVOXIL, INDINAVIR, ZIDOVUDINE, LAMIVUDINE IN VARIOUS DOSE$0
M01 · FY2000 · RR
ADEFOVIR DIPIVOXIL, INDINAVIR, ZIDOVUDINE, LAMIVUDINE IN VARIOUS DOSE$0
M01 · FY2000 · RR
ADEFOVIR DIPIVOXIL, INDINAVIR, ZIDOVUDINE, LAMIVUDINE IN VARIOUS DOSE$0
M01 · FY2000 · RR
ADEFOVIR DIPIVOXIL, INDINAVIR, ZIDOVUDINE, LAMIVUDINE IN VARIOUS DOSE$0
M01 · FY2000 · RR
SCH 56592 IN TREATMENT OF AZOLE REFRACTORY CANDIDIASIS IN HIV$0
M01 · FY2000 · RR
SAQUINAVIR SOFT GEL CAP TID IN COMBO W/ 2 NRTS VS SAQUINAVIR BID IN H$0
M01 · FY2000 · RR
SAQUINAVIR SOFT GEL CAP TID IN COMBO W/ 2 NRTS VS SAQUINAVIR BID IN H$0
M01 · FY2000 · RR
SAQUINAVIR SOFT GEL CAP TID IN COMBO W/ 2 NRTS VS SAQUINAVIR BID IN H$0
M01 · FY2000 · RR
SAQUINAVIR SOFT GEL CAP TID IN COMBO W/ 2 NRTS VS SAQUINAVIR BID IN H$0
M01 · FY2000 · RR
AIDS RELATED NON HODGKINS LYMPHOMA, KAPOSIS SARCOMA &OTHER MALIGNANC$0
M01 · FY2000 · RR
AIDS RELATED NON HODGKINS LYMPHOMA, KAPOSIS SARCOMA &OTHER MALIGNANC$0
M01 · FY2000 · RR
AIDS RELATED NON HODGKINS LYMPHOMA, KAPOSIS SARCOMA &OTHER MALIGNANC$0
M01 · FY2000 · RR